<DOC>
	<DOCNO>NCT01215968</DOCNO>
	<brief_summary>The primary purpose Study help answer follow research question ( ) . - How LY2189265 affect gastric emptying ( speed food drink leave stomach ) patient Type 2 diabetes ? - How LY2189265 affect body handle metformin ( drug use treat Type 2 diabetes ) ? - Is LY2189265 safe side effect associate ? The study participant-blind Week 1 , participant- investigator-blind Week 2 Week 5 . Each participant receive placebo Week 1 once-weekly dos LY2189265 Placebo Weeks 2 5 . Participants take metformin treatment Type 2 Diabetes Mellitus ( T2DM ) continue take metformin part study .</brief_summary>
	<brief_title>A Study Evaluate Effect LY2189265 Speed Which Food Drink Leaves Stomach Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dulaglutide</mesh_term>
	<criteria>1 . Are males female , diagnose Type 2 Diabetes Mellitus great equal 3 month prior screen . 2 . Male patient agree use reliable method birth control study 3 month follow last dose study drug . Female patient must nonchildbearing potential due surgical sterilization menopause . 3 . Have body mass index ( BMI ) 18.5 40.0 kilogram/square meter ( kg/mÂ² ) , inclusive . 4 . Have Type 2 Diabetes Mellitus control diet exercise alone stable single oral antidiabetic medication ( e.g . metformin ) prior screen , take stable dose &gt; 7 day prior first dose occasion . 5 . Have fast blood glucose value screen &gt; 126 milligram/deciliter ( mg/dL ) ( 7.0 [ millimoles/liter ] mmol/L ) patient control diet , &gt; 108 mg/dL ( 6.0 mmol/L ) patient oral antidiabetic medication , upper limit 180 mg/dL ( approximately 9.9 mmol/L ) case . 6 . Have hemoglobin A1c ( HbA1c ) ( indicates average blood glucose level past 3 month ) value screening ( within 4 week prior screen ) 6.5 % 9.5 % . If HbA1c 6.1 % 6.5 % , patient may participate study provide receive permissible oral antidiabetic medication . 7 . Have clinical laboratory test result within normal range determine study doctor . 8 . Can provide enough blood order undergo blood sampling require study . 9 . Are reliable willing make available duration study willing follow study procedure . 10 . Have sign consent form approve Lilly Ethical Review Board ( ERB ) govern site . 11 . Are currently enrol , discontinue within last 30 day , clinical trial involve investigational drug device , concurrently enrol type medical research judge scientifically medically compatible study . 12 . Have previously expose , know allergy glucagonlikepeptide1 ( GLP1 ) relate compound include LY2189265 . 13 . Are person previously complete withdrawn study study investigate LY2189265 receive glucagonlike peptide incretin mimetics past 3 month . 14 . Have take certain Type 2 Diabetes medication within 30 day prior screen . 15 . Have abnormality electrocardiogram ( ECG ) perform screen . 16 . Have poorly control high blood pressure ( systolic blood pressure &gt; 160 millimeter mercury [ mmHg ] and/or diastolic blood pressure &gt; 100 mmHg ) . 17 . Have history presence respiratory , liver , kidney , hormonal , blood , neurological disorder may put patient risk take study medication ; may interfere interpretation data . 18 . Have history presence cardiovascular disorder within last year , sign congestive heart failure , expect require coronary artery bypass surgery angioplasty . 19 . Have history presence pancreatitis certain gastrointestinal disorder . 20 . Have expose radiation clinical trial diagnostic Xray expose routinely via job worker . 21 . Have nonremovable metal object metal plate , screw etc . chest abdominal area . 22 . Have acute diarrhea constipation within 14 day study screen . 23 . Show evidence significant active neuropsychiatric disease . 24 . Regularly use know drug abuse and/or show positive finding urinary drug screening . 25 . Intend start new medication study , include overthecounter herbal medication . 26 . Have donate blood 500 milliliter ( mL ) within last month prior screen . 27 . Have average weekly alcohol intake exceeds study centre 's guideline unwilling adhere alcohol restriction place throughout study . 28 . Smoke 10 cigarette ( equivalent nicotine ) per day , unwilling stop smoking day medication administration unable abide clinical research unit ( CRU ) restriction inpatient day . 29 . Are allergic eggs component meal serve . 30 . Are patient , opinion investigator , way unsuitable participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>